Ruxolitinib Hemifumarate is used to treat myelofibrosis or polycythemia vera, which are bone marrow disorders that that affect your body's ability to produce blood cells. Reference standards of Ruxolitinib Hemifumarate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Ruxolitinib Hemifumarate
Catalogue No.:PA 18 1520000
CAS :
Molecular Formula : C38H40N12O4
Molecular Weight : 728.82
S-Ruxolitinib Hemifumarate
Catalogue No.:PA 18 1521000
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....